We are live on ! Find out more
APC

Alpine Peaks Capital Portfolio holdings

AUM $85.4M
1-Year Est. Return 11.24%
This Fund
S&P 500
This Quarter Est. Return
+8.25%
1 Year Est. Return
+11.24%
3 Year Est. Return
+24.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$143M
AUM Growth
+$10.1M
Cap. Flow
+$530K
Cap. Flow %
0.37%
Top 10 Hldgs %
56.9%
Holding
23
New
–
Increased
9
Reduced
9
Closed
–

Top Buys

Rank Stock Value
1
MRVI icon
Maravai LifeSciences
MRVI
+$1.2M
2
JKHY icon
Jack Henry & Associates
JKHY
+$1.18M
3
RGP icon
Resources Connection
RGP
+$731K
4
EVTC icon
Evertec
EVTC
+$662K
5
HEI.A icon
HEICO Corp Class A
HEI.A
+$402K

Top Sells

Rank Stock Value
1
WST icon
West Pharmaceutical
WST
+$1.22M
2
BFAM icon
Bright Horizons
BFAM
+$676K
3
IPAR icon
Interparfums
IPAR
+$592K
4
USPH icon
US Physical Therapy
USPH
+$507K
5
CGNX icon
Cognex
CGNX
+$455K

Sector Composition

Rank Sector Weight
1 Technology 27.32%
2 Industrials 26.97%
3 Healthcare 24.05%
4 Consumer Discretionary 15.11%
5 Consumer Staples 6.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ROL icon
1
Rollins
ROL
$17.8B
$9.43M 6.62%
220,225
+1,000
+0.5% +$40.6K
IPAR icon
2
Interparfums
IPAR
$3.7B
$9.33M 6.55%
69,014
-4,225
-6% -$592K
MEDP icon
3
Medpace
MEDP
$17.3B
$8.82M 6.19%
36,704
– –
WST icon
4
West Pharmaceutical
WST
$24.8B
$8.45M 5.93%
22,102
-3,425
-13% -$1.22M
CGNX icon
5
Cognex
CGNX
$10.2B
$8.38M 5.88%
149,595
-8,800
-6% -$455K
USPH icon
6
US Physical Therapy
USPH
$1.17B
$8.26M 5.79%
68,037
-4,700
-6% -$507K
EVTC icon
7
Evertec
EVTC
$1.79B
$7.49M 5.25%
203,293
+19,092
+10% +$662K
WAB icon
8
Wabtec
WAB
$50.3B
$7.23M 5.07%
65,950
– –
RHI icon
9
Robert Half
RHI
$4.58B
$7.05M 4.95%
93,761
+2,750
+3% +$196K
BFAM icon
10
Bright Horizons
BFAM
$3.54B
$6.65M 4.66%
71,896
-8,000
-10% -$676K
QLYS icon
11
Qualys
QLYS
$6.3B
$6.25M 4.39%
48,420
– –
TRMB icon
12
Trimble
TRMB
$14B
$5.8M 4.07%
109,616
-2,600
-2% -$127K
APH icon
13
Amphenol
APH
$194B
$5.59M 3.92%
131,530
-5,400
-4% -$210K
SCI icon
14
Service Corp International
SCI
$11.4B
$5.46M 3.83%
84,521
– –
JKHY icon
15
Jack Henry & Associates
JKHY
$11.8B
$5.43M 3.81%
32,425
+7,575
+30% +$1.18M
SYNH
16
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$4.66M 3.27%
110,518
-4,500
-4% -$182K
TREX icon
17
Trex
TREX
$4.77B
$4.62M 3.24%
70,500
+4,300
+6% +$240K
NSP icon
18
Insperity
NSP
$2.02B
$4.15M 2.91%
34,905
– –
MRVI icon
19
Maravai LifeSciences
MRVI
$1.29B
$4.09M 2.87%
329,424
+88,924
+37% +$1.2M
HEI icon
20
HEICO Corp
HEI
$49.6B
$4.04M 2.83%
22,833
-2,000
-8% -$337K
BBSI icon
21
Barrett Business Services
BBSI
$813M
$4.02M 2.82%
184,352
+8,800
+5% +$188K
RGP icon
22
Resources Connection
RGP
$149M
$3.68M 2.58%
234,485
+47,000
+25% +$731K
HEI.A icon
23
HEICO Corp Class A
HEI.A
$36.5B
$3.63M 2.55%
25,830
+3,000
+13% +$402K

Similar funds

ELM
Elite Life Management Sarasota, Florida $85.4M AUM 22.37% 1-Year Est. Return
FWS
FinDec Wealth Services Stockton, California $84.6M AUM 16.09% 1-Year Est. Return
CL
CPWA LLC Hood River, Oregon $86.1M AUM
AFR
Applied Fundamental Research Cambridge, Massachusetts $84.5M AUM 28.46% 1-Year Est. Return
YAG
Yorkville Advisors Global Mountainside, New Jersey $86.2M AUM 41.28% 1-Year Est. Return
N
Naspers South Africa $84.4M AUM 76.38% 1-Year Est. Return
BCM
Beaumont Capital Management Boston, Massachusetts $86.4M AUM 20.04% 1-Year Est. Return
PHIMC
Private Harbour Investment Management & Counsel Sagamore Hills, Ohio $84.3M AUM 23.02% 1-Year Est. Return

Alpine Peaks Capital's Q2 2023 Portfolio in Review

As of Q2 2023, Alpine Peaks Capital held 23 positions worth $143M, up 7.6% from $132M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Trading was light in Q2 2023: portfolio turnover was 0%. Alpine Peaks Capital opened no new positions and made no exits, leaving the 23-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 27% a quarter earlier, followed by Industrials and Healthcare.

  • Alpine Peaks Capital added most to Maravai LifeSciences in Q2 2023, an estimated $1.2M increase.
  • Alpine Peaks Capital's biggest Q2 2023 reduction was West Pharmaceutical, cutting an estimated $1.22M.
  • Alpine Peaks Capital's ten largest holdings make up 57% of its $143M portfolio in Q2 2023.
  • Alpine Peaks Capital opened 0 new positions and closed 0 in Q2 2023.
  • Alpine Peaks Capital's portfolio value rose 7.6% quarter-over-quarter to $143M.

Based on Alpine Peaks Capital's 13F filing for Q2 2023, filed 11 Aug 2023.